Pulse IVL for PAD

About AVS Pulse

AVS Pulse is a private, clinical-stage medical device company pioneering a next-generation intravascular lithotripsy (IVL) system called Pulse IVL™. Its core innovation is a unique mechanism of action that generates rapid pulsatile energy waves to fracture calcified plaques, which is positioned as an improvement over existing IVL technologies in terms of deliverability and ease of use. The company is currently executing a U.S. pivotal IDE study for peripheral artery disease (PAD) and planning expansion into coronary and carotid indications. Backed by a $36M Series B financing, AVS is preparing for a potential U.S. commercial launch in the competitive calcified lesion treatment market.

Therapeutic Areas